Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Collegium Pharmaceutical (COLL) Short-term Investments: 2023-2024

Historic Short-term Investments for Collegium Pharmaceutical (COLL) over the last 2 years, with Dec 2024 value amounting to $92.2 million.

  • Collegium Pharmaceutical's Short-term Investments rose 67.62% to $135.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $135.8 million, marking a year-over-year increase of 67.62%. This contributed to the annual value of $92.2 million for FY2024, which is 28.77% up from last year.
  • According to the latest figures from FY2024, Collegium Pharmaceutical's Short-term Investments is $92.2 million, which was up 28.77% from $71.6 million recorded in FY2023.
  • Over the past 5 years, Collegium Pharmaceutical's Short-term Investments peaked at $92.2 million during FY2024, and registered a low of $71.6 million during FY2023.
  • In the last 2 years, Collegium Pharmaceutical's Short-term Investments had a median value of $81.9 million in 2023 and averaged $81.9 million.
  • Data for Collegium Pharmaceutical's Short-term Investments shows a peak YoY climbed of 28.77% (in 2024) over the last 5 years.
  • Over the past 2 years, Collegium Pharmaceutical's Short-term Investments (Yearly) stood at $71.6 million in 2023, then rose by 28.77% to $92.2 million in 2024.